Statistics

Total Visits

Views
Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial34

Select a period of time:

Number of views in the range

Views
Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial21

Views

Views
January 20250
February 20250
March 202515
April 20252
May 20250
June 20254
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States4
Brazil1
Spain1
 

Top cities views

Views
Council Bluffs1
Phoenix1
Rainsville1
Salvador1
Youngstown1